RNA interference mediated inhibition of TNF and TNF receptor superfamily gene expression using short interfering nucleic acid (siNA)

Details for Australian Patent Application No. 2003217550 (hide)

Owner RIBOZYME PHARMACEUTICALS, INCORPORATED

Inventors Beigelman, Leonid; McSwiggen, James

Agent Spruson & Ferguson

Pub. Number AU-A-2003217550

PCT Number PCT/US03/04741

PCT Pub. Number WO2003/070897

Priority 60/408,378 05.09.02 US; 60/409,293 09.09.02 US; 60/429,359 28.11.02 US; 60/440,129 15.01.03 US; 60/358,580 20.02.02 US; 60/363,124 11.03.02 US; 60/386,782 06.06.02 US; 60/406,784 29.08.02 US

Filing date 20 February 2003

Wipo publication date 9 September 2003

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/408,378 05.09.02 US; 60/409,293 09.09.02 US; 60/429,359 28.11.02 US; 60/440,129 15.01.03 US; 60/358,580 20.02.02 US; 60/363,124 11.03.02 US; 60/386,782 06.06.02 US; 60/406,784 29.08.02 US

9 October 2003 Application Open to Public Inspection

  Published as AU-A-2003217550

18 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003217551-Knee arthroplasty prosthesis and method

2003217549-Dry dust control materials